Recursion Pharmaceuticals Stock Target Price and Analyst Consensus
| RXRX Stock | USD 7.07 0.69 10.82% |
The current analyst and expert consensus on Recursion Pharmaceuticals is Buy with 6 hold recommendations. The current projected Recursion Pharmaceuticals target price consensus is 16.83 with 8 analyst opinions. One of the most common ways Recursion Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Recursion Pharmaceuticals vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Recursion Pharmaceuticals. We strongly encourage you to use your own analysis of Recursion Pharmaceuticals to validate this buy or sell advice. Recursion Pharmaceuticals recommendation module provides expert sentiment on the projected Recursion Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 4.0844.
Lowest Forecast 15.32 | Highest Forecast 18.68 | Target Price 16.83 |
Recursion |
It's important to approach Recursion Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Recursion Pharmaceuticals price targets
Recursion Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Recursion Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Recursion Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Recursion Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Recursion Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Recursion Pharmaceuticals is a key component of Recursion Pharmaceuticals valuation and have some predictive power on the future returns of a Recursion Pharmaceuticals.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Blockchain Invested few shares | |
 | Cash Cows Invested few shares | |
 | Corona Opportunity Invested few shares | |
 | Dividend Beast Invested over 50 shares | |
 | Baby Boomer Prospects Invested over 60 shares | |
 | Business Services Invested few shares | |
 | Automobiles and Trucks Invested over 200 shares | |
 | Momentum Invested over 200 shares | |
 | ESG Investing Invested few shares | |
 | Banking Invested over 40 shares | |
Additional Tools for Recursion Stock Analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.